Effectiveness and Tolerability of Influenza Vaccine in Patients at Risk for Severe and Complicated Influenza

NCT06286488 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

1500

Enrollment

OTHER

Sponsor class

Conditions

Influenza
Obesity
Pregnancy; Infection
Elderly Infection
Vaccine Reaction
Vaccine Adverse Reaction
Tolerance

Interventions

DRUG: Vaxigrip

Sponsor

Medical University of Warsaw